glp-1 launch Medicare to GLP-1s for $50: Here's what to know GLP-1 Oral Solution – Affordable

Only the United States and New Zealand allow direct-to-consumer prescription drug advertising

Larazotide is currently being studied for illnesses of intestinal permeability and is the subject of a late-phase clinical trial for patients with celiac disease, whose intestinal barrier is compromised

Fatigue Autoimmune-related fatigue is among the most debilitating and difficult-to-treat symptoms patients face

PubMed, Kronenberg, F., and G

Managing Gout Risk While Taking Wegovy For patients taking Wegovy who are concerned about gout or who have a history of the condition, several practical strategies can help minimise risk and support safe, effective weight loss

Food and Drug Administration (FDA), as a treatment for weight lossso the research on these drugs, and their long-term side effects and risks, is still nascent